# Avalo Therapeutics (AVTX) — News

AVTX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/avtx/news

## Recent headlines

- [Avalo Therapeutics - selling stockholders may sell up to 128,189 shares of common stock - SEC filing](https://www.ainvest.com/news/avalo-therapeutics-selling-stockholders-sell-128-189-shares-common-stock-sec-filing-2607) — AInvest Wire, Jul 28, 2026
  Avalo Therapeutics, Inc. (NASDAQ: AVTX) has announced a public offering of its common stock and pre-funded warrants to purchase shares of its common stock. The offering is being conducted under a shelf registration statement on Form S-3, which was filed with the U.S. Securities and Exchange…
- [Avalo Therapeutics Inc: Leerink Partners initiates coverage with outperform rating; target price $38](https://www.ainvest.com/news/avalo-therapeutics-leerink-partners-initiates-coverage-outperform-rating-target-price-38-2607) — AInvest Wire, Jul 6, 2026
  Leerink Partners has initiated coverage of Avalo Therapeutics Inc (NASDAQ: AVLO) with an "outperform" rating and a target price of $38 per share. The firm's decision follows a series of recent financing activities led by Avalo, including a $125 million follow-on offering in February 2023 and a $150…
- [Avalo Therapeutics appoints Ron Philip to board of directors](https://www.ainvest.com/news/avalo-therapeutics-appoints-ron-philip-board-directors-2606) — AInvest Wire, Jun 23, 2026
- **Important** — Avalo Therapeutics announces 1-for-240 reverse stock split — AInvest Wire, Dec 27, 2023
  Avalo Therapeutics announces 1-for-240 reverse stock split Avalo Therapeutics, a biopharmaceutical company, announced on July 6, 2022, that it will be implementing a one-for-twelve reverse stock split of its common stock [1]. This move aims to increase the per share price of its common stock to…
- **Important** — Avalo Therapeutics shares surge 29% in premarket trading as Co. plans to sell 800 Series programs to AUG Therapeutics. — AInvest Wire, Sep 14, 2023

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).